Re: The cardiac pre-print now published....in Cell!
in response to
by
posted on
Mar 16, 2021 05:34PM
As RVX has no track record in infectious diseases there's no possibility they will have much say in the design of the covid trial. It will be designed by experts.
What's more a trial of this type will cost peanuts compared with something like BoM. So we don't have to worry about that either.
We can sleep!